盐酸氨溴索注射液联合酚妥拉明注射液治疗小儿重症肺炎的疗效
2019-09-25郑婵娟
郑婵娟

摘要:目的 觀察盐酸氨溴索注射液联合酚妥拉明注射液治疗小儿重症肺炎的临床疗效。方法 选取2017年2月~2018年2月在我院诊治的140例小儿重症肺炎患儿作为研究对象,随机分为对照组和观察组,各70例。对照组采用常规治疗,观察组在对照组基础上给予盐酸氨溴索注射液联合酚妥拉明注射液治疗,对比两组临床治疗有效率、临床症状消失时间(发热、咳嗽、气促、湿啰音、心衰)及不良反应发生情况。结果 观察组治疗总有效率为94.28%,高于对照组的78.57%,差异有统计学意义(P<0.05);观察组临床症状消失时间(发热、咳嗽、气促、湿啰音、心衰)均短于对照组,差异有统计学意义(P<0.05);观察组不良反应发生率为5.71%,低于对照组的28.57%,差异有统计学意义(P<0.05)。结论 盐酸氨溴索注射液联合酚妥拉明注射液治疗小儿重症肺炎疗效确切,临床症状消退时间短,应用安全性高,可促进患儿的快速恢复。
关键词:盐酸氨溴索;酚妥拉明;小儿;重症肺炎
中图分类号:R725.6 文献标识码:A DOI:10.3969/j.issn.1006-1959.2019.16.045
文章编号:1006-1959(2019)16-0136-02
Abstract:Objective To observe the clinical efficacy of ambroxol hydrochloride injection combined with phentolamine injection in the treatment of severe pneumonia in children.Methods A total of 140 children with severe pneumonia in our hospital from February 2017 to February 2018 were enrolled in the study. They were randomly divided into the control group and the observation group, 70 cases each. The control group was treated with conventional therapy. The observation group was treated with ambroxol hydrochloride injection combined with phentolamine injection on the basis of the control group. The clinical treatment efficiency and clinical symptom disappearance time (fever, cough, shortness of breath, wetness Voice, heart failure) were compared between the two groups and adverse reactions.Results The total effective rate of the observation group was 94.28%, which was higher than that of the control group 78.57%,the difference was statistically significant (P<0.05). The clinical symptoms disappeared in the observation group (fever, cough, shortness of breath, wet voice, heart failure),the difference was statistically significant (P<0.05). The incidence of adverse reactions in the observation group was 5.71%, which was lower than that in the control group 28.57%,the difference was statistically significant (P<0.05). Conclusion Ambroxol hydrochloride injection combined with phentolamine injection is effective in the treatment of severe pneumonia in children. The clinical symptoms are short and the application safety is high, which can promote the rapid recovery of children.
Key words:Ambroxol hydrochloride;Phentolamine;Pediatric;Severe pneumonia
小儿重症肺炎病情危重,发展快,且合并多种并发症,容易造成心力衰竭,危及患者的生命,应采取积极有效的措施治疗小儿重症肺炎,以确保患儿的生命安全[1]。临床常规给予抗感染、抗病毒治疗,治疗效果不理想。研究显示,采用盐酸氨溴索联合酚妥拉明注射液可以取得理想的效果,尤其是可在短时间内使临床症状减轻、消退[2]。本研究选取2017年2月~2018年2月我院诊治的140例小儿重症肺炎患儿作为研究对象,探讨盐酸氨溴索注射液联合酚妥拉明注射液治疗小儿重症肺炎的疗效,现报告如下。
1资料与方法
1.1一般资料 选取2017年2月~2018年2月在佳木斯市中心医院诊治的140例小儿重症肺炎患儿临床资料,采用随机数字表法分为对照组和观察组,各70例。纳入标准:①符合《实用儿科学》中关于重症肺炎的相关诊断标准[3];②年龄3~12岁,伴有咳嗽、发热症状;③肺部存在湿啰音;④X线片显示有斑片状阴影或大片状阴影。……
